Lefrandt, Joop D.

Validity of (ultra-)short recordings for heart rate variability measurements.

Munoz, M. L., van Roon, A., Riese, H., Thio, C., Oostenbroek, E., Westrik, I., de Geus, E. J. C., Gansevoort, R., Lefrandt, J., Nolte, I. M., et al. (2015) · PLOS ONE

Heart Rate Variability and Autonomic ControlECG Monitoring and Analysis

Cited by 423

Long-Term Cardiovascular Mortality in Patients With Differentiated Thyroid Carcinoma: An Observational Study

Klein Hesselink, E. N., Klein Hesselink, M. S., de Bock, G. H., Gansevoort, R. T., Bakker, S. J. L., Vredeveld, E. J., van der Horst-Schrivers, A. N. A., van der Horst, I. C. C., Kamphuisen, P. W., Plukker, J. T. M., et al. (2013) · Journal of Clinical Oncology

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and Treatments

Cited by 183

Increased α-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis

Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition

Fatty Acid Research and HealthNutritional Studies and Diet

Cited by 123

Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease

de Vos, L. C., Lefrandt, J. D., Dullaart, R. P. F., Zeebregts, C. J., & Smit, A. J. (2016) · Atherosclerosis

Advanced Glycation End Products researchPeripheral Artery Disease Management

Cited by 77